WHO ICTRP trial

In patients undergoing ultrasound-guided fascia iliaca compartment blockade…

ACTRN12612000401853 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12612000401853
Public title In patients undergoing ultrasound-guided fascia iliaca compartment blockade before knee replacement surgery, does the addition of hyaluronidase to the local anaesthetic solution improve the success rate and hasten the onset of the nerve blockade?
Scientific title Does the addition of hyaluronidase to ultrasound-guided fascia iliaca compartment block improve the time to onset and extent of anaesthesia in patients undergoing unlilateral knee arthroplasty?
Primary sponsor Dr Andrew Kenneth Lansdown
Secondary sponsors Dr John Loadsman
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 4
Countries Australia
Conditions Improving regional anaesthesia efficacy; Improving regional anaesthesia efficacy;Anaesthesiology - Anaesthetics;Musculoskeletal - Other muscular and skeletal disorders
Interventions 30mL 0.5% ropivacaine with/without hyaluronidase powder 1500IU (i.e. 50IU/mL hyaluronidase) will be used for fascia iliaca compartment block. A single block fascia iliaca compartment procedure is performed approximately 30minutes before…
Registration date Oct 4, 2012
Target size 100
Secondary IDs Nil
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations